ELTX
Elicio Therapeutics
$3.00
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame ELTX today
- Market cap
- $57.26M
- P/E (TTM)
- -1.4
- EV / FCF
- -1.5
- ROIC
- -271.5%
- Div yield
- 0%
- 52wk Low
- $2.66
- 52wk High
- $16.00
Growth
Revenue and earnings trend for ELTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ELTX
Is Elicio Therapeutics a good buy?
No. Elicio Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Elicio Therapeutics is selling at a very high price.
What is the market capitalization of ELTX?
Elicio Therapeutics's market capitalization is $57.26M.
What is the P/E ratio for ELTX stock?
Elicio Therapeutics's current P/E ratio is -1.4.
What is the 52-week high for ELTX stock?
The 52-week high for Elicio Therapeutics is $16.00. The current close of $3.00 is 81.3% below that high.
What is the 52-week low for ELTX stock?
The 52-week low for Elicio Therapeutics is $2.66. The current close of $3.00 is 12.8% above that low.
Does ELTX stock pay dividends?
Elicio Therapeutics does not currently show a dividend per share in the company data.